Sight Sciences Stock (NASDAQ:SGHT)
Previous Close
$6.02
52W Range
$1.04 - $8.45
50D Avg
$6.29
200D Avg
$5.80
Market Cap
$299.33M
Avg Vol (3M)
$169.57K
Beta
2.70
Div Yield
-
SGHT Company Profile
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
SGHT Performance
Peer Comparison
| Ticker | Company |
|---|---|
| FNA | Paragon 28, Inc. |
| ANIK | Anika Therapeutics, Inc. |
| RPID | Rapid Micro Biosystems, Inc. |
| OFIX | Orthofix Medical Inc. |
| AVNS | Avanos Medical, Inc. |
| VREX | Varex Imaging Corporation |
| LUNG | Pulmonx Corporation |
| NPCE | NeuroPace, Inc. |
| KIDS | OrthoPediatrics Corp. |
| SIBN | SI-BONE, Inc. |
| AORT | Artivion, Inc. |
| TCMD | Tactile Systems Technology, Inc. |
| CVRX | CVRx, Inc. |
| CNMD | CONMED Corporation |